Schreiner MediPharm, a global innovator in functional labeling and smart packaging solutions for the healthcare sector, is set to unveil its latest syringe security advancement — Cap-Lock plus RFID — at CPHI Frankfurt from October 28–30. The new system combines enhanced mechanical tamper protection with embedded digital RFID tracking, creating a comprehensive security solution designed for prefilled syringes used across pharmaceutical and hospital environments.
Displayed at Booth #8.0B42, Schreiner MediPharm’s Cap-Lock plus RFID will be demonstrated in collaboration with SCHOTT Pharma’s TOPPAC infuse COC prefillable syringes, highlighting how secure labeling and smart identification technologies can work together to advance drug safety, supply chain visibility, and environmental sustainability.
Building on the company’s existing Cap-Lock Label technology, the Cap-Lock plus RFID introduces a refined tamper-evident cap-and-label system that fully encloses both the syringe barrel and closure. The specially engineered cap, which matches the diameter of the syringe barrel, ensures a tight and reliable seal. Once the cap is opened, an irreversible first-opening indicator built into the label activates, making it immediately evident if the syringe has been previously accessed.
This mechanical safeguard eliminates the need for secondary blister packaging, reducing both material consumption and the associated CO₂ footprint during packaging and logistics. By streamlining handling, transportation, and storage, the solution delivers measurable efficiency gains across pharmaceutical supply chains — a key factor for sustainability-driven manufacturers and healthcare distributors.
The defining feature of Cap-Lock plus RFID, however, lies in its integrated radio-frequency identification (RFID) functionality. Embedded within the label, the RFID chip introduces a digital layer of traceability and verification that works alongside the physical first-opening indicator. In hospital settings, this dual protection enables automated integrity tracking of individual syringes from production through final administration — effectively replacing manual inspection steps and improving workflow reliability for healthcare professionals.
“Cap-Lock plus RFID represents a major leap forward in securing prefilled syringes,” said a Schreiner MediPharm spokesperson. “By merging tamper evidence with digital data connectivity, we’re helping manufacturers and hospitals achieve both greater product safety and smarter operational control.”
Through RFID integration, the system provides unit-level identification for every syringe, making it compatible with digital inventory systems. Hospitals can instantly verify if a syringe has been opened, track expiration dates, and even flag potential drug diversion or misuse. The RFID chip allows automated re-entry of unused prefilled syringes into inventory and immediate detection of expired doses, strengthening compliance with pharmaceutical handling standards while reducing waste.
For pharmaceutical manufacturers, the innovation offers clear production and operational advantages. Schreiner MediPharm engineered the label’s multilayer construction to ensure mechanical durability and protect the embedded chip from damage during high-speed filling and labeling processes. This robust design prevents functional failures and guarantees reliable chip readability throughout manufacturing, logistics, and clinical use. The result is lower downtime, reduced material waste, and consistent quality control — key drivers of cost efficiency and production continuity.
Cap-Lock plus RFID is compatible with existing syringe manufacturing systems and dispensing lines, ensuring drop-in integration without major process redesigns. It also supports a variety of pharmaceutical packaging workflows, from bulk hospital distribution to individualized dose tracking for advanced therapies.
By linking physical tamper protection with real-time digital monitoring, Schreiner MediPharm’s innovation reflects a broader trend in healthcare toward digitalized packaging intelligence. Smart label technologies like RFID are increasingly used to ensure product authenticity, supply chain transparency, and patient safety, particularly for injectable medications and biologics that require meticulous traceability.
Furthermore, the elimination of additional blister packs contributes to Schreiner MediPharm’s sustainability objectives, aligning with global efforts to reduce plastic use and packaging waste in the pharmaceutical industry. By cutting material consumption and transport volume, the solution supports pharmaceutical companies’ goals of achieving lower environmental impact and leaner logistics.
Based in the Munich region of Germany, Schreiner MediPharm has more than 70 years of experience in high-performance labeling technologies. The family-owned company serves leading global healthcare and pharmaceutical brands, delivering functional specialty labels that integrate safety, connectivity, and user convenience. Its portfolio spans RFID-enabled smart labels, autoinjector safety seals, multi-functional dosing aids, and a wide range of custom-engineered packaging solutions designed to meet evolving regulatory and clinical demands.
With Cap-Lock plus RFID, Schreiner MediPharm reinforces its position at the forefront of pharmaceutical digitalization and product security, offering a solution that protects patients, supports sustainability, and prepares healthcare supply chains for the next era of connected medicine.
The unveiling of Cap-Lock plus RFID at CPHI Frankfurt marks more than just a packaging innovation — it represents a tangible step toward digitalized healthcare ecosystems, where medical products are not only physically secure but also digitally connected throughout their lifecycle. With its combination of tamper-evident labeling and embedded RFID technology, Schreiner MediPharm’s solution is designed to close long-standing gaps in drug traceability, automated inventory control, and patient protection.
In modern hospitals and pharmaceutical supply chains, the movement of high-value or sensitive injectables is still largely tracked through manual documentation and visual inspection. This process is time-consuming and prone to human error. Cap-Lock plus RFID transforms this landscape by enabling automatic, contactless verification of every individual syringe — from the moment it leaves the manufacturing facility to its administration in a clinical setting.
Each RFID tag embedded within the Cap-Lock label carries a unique electronic product code (EPC), making it possible to identify and authenticate single doses instantly. When integrated into a hospital’s digital infrastructure, this data allows staff to confirm a syringe’s status — unopened, expired, or previously used — without manual handling or visual checks. The result is a workflow that is not only faster and more reliable, but also safer and more compliant with global medical regulations.
Schreiner MediPharm’s engineers designed the RFID system to provide both physical and digital first-opening indicators, creating a dual-layer verification model. The analog seal visually confirms whether the syringe has been accessed, while the RFID chip automatically transmits this information to the facility’s monitoring system. This digital confirmation eliminates ambiguity, ensuring that no compromised or previously opened syringes are inadvertently used.
The implications for patient safety are significant. Hospitals often manage thousands of prefilled syringes for routine injections, vaccinations, or emergency procedures. By embedding RFID into each unit, clinicians can verify drug integrity, dosage accuracy, and expiration dates with a quick scan. The system also supports automatic alerts for expiring stock, preventing medication waste and reducing the risk of administering out-of-date drugs.
“Cap-Lock plus RFID creates transparency where it’s most needed,” said a Schreiner MediPharm representative. “It transforms the syringe from a static product into a smart medical asset, capable of communicating its history, authenticity, and usability in real time.”
Beyond healthcare facilities, the technology also delivers value across the pharmaceutical logistics chain. In production and distribution, RFID enables unit-level traceability, allowing manufacturers and wholesalers to maintain a continuous digital record of every prefilled syringe — including batch information, packaging date, and shipment details. This ensures compliance with global serialization and anti-counterfeiting requirements, while simplifying product recalls and verification processes.
The robust label construction of Cap-Lock plus RFID guarantees that the embedded chip remains functional through the rigors of manufacturing, sterilization, and transport. Its multilayer protection shields the RFID inlay from mechanical stress, static discharge, and chemical exposure, ensuring consistent readability even on high-speed packaging lines. This durability is critical for large-scale pharmaceutical operations where reliability and machine compatibility are essential.
From a sustainability standpoint, the new solution also aligns with eco-conscious manufacturing goals. By eliminating the need for additional blister packaging, pharmaceutical companies can achieve meaningful reductions in CO₂ emissions and plastic waste. This streamlined packaging design translates to lower transport weight and improved warehouse efficiency — practical advantages that contribute to both environmental stewardship and cost savings.
In the long term, Schreiner MediPharm envisions its RFID-enabled Cap-Lock system as part of a larger digital health ecosystem. When integrated with hospital inventory platforms, cloud-based pharmaceutical databases, or Internet of Things (IoT) networks, each smart syringe can become a data point in real-time medical asset management. Hospitals could automatically update stock levels, generate replenishment orders, and maintain complete usage histories without manual input — reducing administrative workloads while improving accuracy.
Moreover, the digital data captured through RFID can enhance pharmacovigilance efforts by linking medication information directly to electronic health records (EHRs). This capability could help healthcare providers trace specific medication batches used in treatments, enabling rapid response in the event of recalls or adverse drug reactions.
Schreiner MediPharm’s approach demonstrates how smart packaging is evolving from a logistical convenience into a critical element of healthcare innovation. As digital health technologies mature, connected packaging systems like Cap-Lock plus RFID are expected to play a central role in drug authentication, patient safety, and global supply chain security.
The collaboration between Schreiner MediPharm and SCHOTT Pharma further highlights the industry’s shift toward integrated solutions that bridge materials science, digitalization, and clinical usability. By combining SCHOTT’s high-performance polymer syringes with Schreiner’s intelligent labeling technology, the partnership offers a holistic systemthat meets the dual demands of safety and digital efficiency.
With more than seven decades of expertise, Schreiner MediPharm continues to position itself at the intersection of packaging innovation and pharmaceutical technology. The company’s development of Cap-Lock plus RFID illustrates how even a simple component — the syringe cap — can be reimagined into a smart safety device that enhances control, efficiency, and sustainability throughout the product lifecycle.
As the healthcare industry accelerates its digital transformation, solutions like Schreiner MediPharm’s RFID-enabled Cap-Lock are setting new standards for traceability, transparency, and trust — ensuring that every syringe, from production to patient, remains protected, verifiable, and connected in the digital age.
Powered by Froala Editor